[1]Liu B, Li S, Sui X, et al. Root Extract of Polygonum cuspidatum Siebold & Zucc. Ameliorates DSS-induced ulcerative colitis by affecting NF-kappaB signaling pathway in a mouse model via synergistic effects of polydatin,resveratrol, and emodin[J]. Front Pharmacol,2018,9:347.
[2]时圣明,潘明佳,王文倩,等. 虎杖的化学成分及药理作用研究进展[J]. 药物评价研究,2016,39(2):313-317.
[3]Li W, Zhang Q, Chen K, et al. 2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC cancer stem cells[J]. BMC Complement Altern Med,2019,19(1):38.
[4]Wu X, Li Q, Feng Y, et al. Antitumor research of the active ingredients from traditional Chinese medical plant Polygonum cuspidatum[J]. Evid Based Complement Alternat Med,2018,2018:2313021.
[5]Wang YL, Horng CT, Hsieh MT, et al. Autophagy and apoptotic machinery caused by Polygonum cuspidatum extract in cisplatinresistant human oral cancer CAR cells[J]. Oncol Rep,2019,41(4):2549-2557.
[6]Zhang Q, Tan Y, Zhang N, et al. Polydatin supplementation ameliorates diet-induced development of insulin resistance and hepatic steatosis in rats[J]. Mol Med Rep,2015,11(1):603-610.
[7]Hopkins AL. Network pharmacology[J]. Nat Biotechnol,2007,25(10):1110-1111.
[8]章水晶,杜仲燕. 基于网络药理学研究丹参治疗帕金森病的作用机制[J]. 中国临床药理学与治疗学,2019,24(6):601-607.
[9]Li S. Exploring traditional chinese medicine by a novel therapeutic concept of network target[J]. Chinese Journal of Integrative Medicine,2016,22(9):647-652.
[10]周文霞,王同兴,程肖蕊,等. 网络药理学研究中的网络分析技术[J]. 国际药学研究杂志,2016,43(3):399-409.
[11]Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform,2014,6:13.
[12]Xu X, Zhang W, Huang C, et al. A novel chemometric method for the prediction of human oral bioavailability[J]. Int J Mol Sci,2012,13(6):6964-6982.
[13]Luo H, Chen J, Shi L, et al. DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome[J]. Nucleic Acids Res,2011,39(Web Server issue):W492-W498.
[14]Wang Y, Ye J, Li J, et al. Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9)[J]. Cardiovascular Diabetology,2016,15(1):19-25.
[15]Asgary S, Karimi R, Momtaz S, et al. Effect of resveratrol on metabolic syndrome components: A systematic review and meta-analysis[J]. Rev Endocr Metab Disord,2019,20(2):173-186.
[16]Lasa A, Schweiger M, Kotzbeck P, et al. Resveratrol regulates lipolysis via adipose triglyceride lipase[J]. The Journal of Nutritional Biochemistry,2012,23(4):379-384.
[17]Mollazadeh H, Mahdian D, Hosseinzadeh H. Medicinal plants in treatment of hypertriglyceridemia: A review based on their mechanisms and effectiveness[J]. Phytomedicine,2019,53:43-52.
[18]Aubert C E, Rodondi N. 2018 new recommendations for dyslipidemia : a critical review of evidence[J]. Rev Med Suisse,2018,14(596):456-460.
[19]He C, Fu P, Zhang K, et al. Chinese herbal medicine for dyslipidemia: protocol for a systematic review and meta-analysis[J]. Medicine (Baltimore),2018,97(44):e13048.
[20]李梢. 中医证候生物分子网络标志的构想与研究[J]. 中医杂志,2009,50(9):773-776.
[21]Wu X, Li Q, Feng Y, et al. Antitumor research of the active ingredients from traditional Chinese medical plant polygonum cuspidatum[J]. Evid Based Complement Alternat Med,2018,2018:2313021.
[22]郑丽, 鲍轶, 吴加元, 等.虎杖苷对3T3-L1前脂肪细胞增殖与分化的影响及其作用机制[J]. 中华中医药学刊,2017,35(10): 2521-2525.
[23]张慧,郑丽,鲍轶.白芦藜醇影响前脂肪细胞增殖与分化及调控相关信号通路的研究[J].中华中医药学刊,2018,36(4):833-837.
[24]Mo JF, Wu JY, Zheng L, et al. Therapeutic efficacy of polydatin for nonalcoholic fatty liver disease via regulating inflammatory response in obese mice[J]. RSC Advances, 2018,8: 31194-31200. |